Literature DB >> 12799282

Angiogenic factors reconstitute hematopoiesis by recruiting stem cells from bone marrow microenvironment.

Shahin Rafii1, Scott Avecilla, Sergey Shmelkov, Koji Shido, Rafael Tejada, Malcolm A S Moore, Beate Heissig, Koichi Hattori.   

Abstract

The mechanism by which angiogenic factors recruit bone marrow (BM)-derived quiescent endothelial and hematopoietic stem cells (HSCs) is not known. Here, we report that functional vascular endothelial growth factor receptor-1 (VEGFR1, Flt-1) is expressed on a subpopulation of human CD34(+) and mouse Lin-Sca-1(+)c-Kit(+) BM-repopulating stem cells, conveying signals for recruitment of HSCs and reconstitution of hematopoiesis. Inhibition of VEGFR1 signaling, but not VEGFR2 (Flk-1, KDR), blocked HSC cell cycling, differentiation and hematopoietic recovery after BM suppression, resulting in the demise of the treated mice. Plasma elevation of placental growth factor (PlGF), which signals through VEGFR1, but not VEGFR2, restored hematopoiesis during the early and late phases following BM suppression. The mechanism whereby PlGF enhanced early phases of BM recovery was mediated directly through rapid chemotaxis of readily available VEGFR1(+) BM-repopulating and progenitor cells. The late phase of hematopoietic recovery was driven by PlGF-induced upregulation of matrix metalloproteinase-9 (MMP-9) in the BM, mediating the release of soluble Kit-ligand (sKitL). sKitL increased proliferation and motility of HSCs and progenitor cells, thereby augmenting hematopoietic recovery. PlGF promotes recruitment of VEGFR1(+) HSCs from a quiescent to a proliferative microenvironment within the BM, favoring differentiation, mobilization, and reconstitution of hematopoiesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12799282     DOI: 10.1111/j.1749-6632.2003.tb03232.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  40 in total

1.  NADPH oxidase 2 regulates bone marrow microenvironment following hindlimb ischemia: role in reparative mobilization of progenitor cells.

Authors:  Norifumi Urao; Ronald D McKinney; Tohru Fukai; Masuko Ushio-Fukai
Journal:  Stem Cells       Date:  2012-05       Impact factor: 6.277

2.  TIMP-2 targets tumor-associated myeloid suppressor cells with effects in cancer immune dysfunction and angiogenesis.

Authors:  Liliana Guedez; Sandra Jensen-Taubman; Dimitra Bourboulia; Clifford J Kwityn; Beiyang Wei; John Caterina; William G Stetler-Stevenson
Journal:  J Immunother       Date:  2012-07       Impact factor: 4.456

3.  Antiangiogenesis cocktails - stirred or shaken?

Authors:  Sara M Mariani
Journal:  MedGenMed       Date:  2004-10-20

4.  Bone marrow-derived lin(-)c-kit(+)Sca-1+ stem cells do not contribute to vasculogenesis in Lewis lung carcinoma.

Authors:  Vivek R Shinde Patil; Erik B Friedrich; Allison E Wolley; Robert E Gerszten; Jennifer R Allport; Ralph Weissleder
Journal:  Neoplasia       Date:  2005-03       Impact factor: 5.715

Review 5.  Angiogenesis and vasculogenesis: inducing the growth of new blood vessels and wound healing by stimulation of bone marrow-derived progenitor cell mobilization and homing.

Authors:  Omaida C Velazquez
Journal:  J Vasc Surg       Date:  2007-06       Impact factor: 4.268

6.  Tie2 activation contributes to hemangiogenic regeneration after myelosuppression.

Authors:  Hans-Georg Kopp; Scott T Avecilla; Andrea T Hooper; Sergey V Shmelkov; Carlos A Ramos; Fan Zhang; Shahin Rafii
Journal:  Blood       Date:  2005-04-07       Impact factor: 22.113

7.  Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha.

Authors:  Katherine A Gallagher; Zhao-Jun Liu; Min Xiao; Haiying Chen; Lee J Goldstein; Donald G Buerk; April Nedeau; Stephen R Thom; Omaida C Velazquez
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

8.  Role of vitamin D receptor in the antiproliferative effects of calcitriol in tumor-derived endothelial cells and tumor angiogenesis in vivo.

Authors:  Ivy Chung; Guangzhou Han; Mukund Seshadri; Bryan M Gillard; Wei-dong Yu; Barbara A Foster; Donald L Trump; Candace S Johnson
Journal:  Cancer Res       Date:  2009-01-13       Impact factor: 12.701

Review 9.  PlGF: a multitasking cytokine with disease-restricted activity.

Authors:  Mieke Dewerchin; Peter Carmeliet
Journal:  Cold Spring Harb Perspect Med       Date:  2012-08-01       Impact factor: 6.915

10.  Tumor angiogenesis: insights and innovations.

Authors:  Fernando Nussenbaum; Ira M Herman
Journal:  J Oncol       Date:  2010-04-26       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.